EQB Inc. (EQB)
Toronto Exchange · Canada · prices in CAD · close of 23 Oct 2026
Key indicators
| Last close | CAD 117.66 |
|---|---|
| 52-week range | 83.93 – 150.32 |
| Return, 1 month / 3 months | −5.8% / −14.6% |
| Return, 1 year / 3 years | +34.8% / +82.5% |
| Trend | Below its 200-day average |
| RSI (14) | 35 |
| Volatility (1 year) | 28.1% |
| Worst drawdown (1 year) | -21.0% |
| Average daily value traded | 15.19M CAD |
| Dividend yield | 2.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
EQB Inc. is a Canadian financial services company based in Toronto. Through its main subsidiary, Equitable Bank, it provides residential mortgages, including alternative and reverse mortgage products, along with savings accounts and commercial lending. Its customers are mainly individual borrowers and savers in Canada, served through branchless, digital channels and broker networks. The company also operates through specialised lending and trust businesses that support its banking activities.
EQB Inc. trades under the code EQB on the Toronto Exchange in Canada, with its price quoted in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
EQB Inc. (EQB) trades on the Toronto Exchange in Canada. It last closed at CAD 117.66 on 23 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 307 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 34.8% and over the last three months it fell 14.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 53 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -2.7% | ||
| From 52-week high | -21.4% | ||
| Momentum | 48 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -14.6% | ||
| 6-month return | -2.1% | ||
| 12-month return, skipping the last month | 43.1% | ||
| Stability (higher is calmer) | 70 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 28.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.0% | ||
| Liquidity | 81 · Strong | Trades actively. | |
| Average daily value traded | 15.19M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 53 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.0% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −3.0% |
|---|---|
| 1 month | −5.8% |
| 3 months | −14.6% |
| 6 months | −2.1% |
| 1 year | +34.8% |
| 3 years | +82.5% |
| 5 years | +70.1% |
Signals
| 50-day / 200-day average | 126.86 / 120.97 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 2.51 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Sep 2026 | CAD 0.6300 |
| 15 Jun 2026 | CAD 0.6100 |
| 13 Mar 2026 | CAD 0.5900 |
| 15 Dec 2025 | CAD 0.5700 |
| 15 Sep 2025 | CAD 0.5500 |
| 13 Jun 2025 | CAD 0.5300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.